IDiyas

For the Inventor, By the Inventor

Sakai, Japan

Tadashi Iso

USPTO Granted Patents = 33

Average Co-Inventor Count = 3.3

ph-index = 7

Forward Citations = 162(Granted Patents)


Location History:

  • Kyoto, JP (1984)
  • Tondabayashi, JP (1979 - 1985)
  • Sakai, JP (1984 - 1988)
  • Kawachinagano, JP (1991 - 1994)

Company Filing History:

goldMedal33 out of 281 
 
Santen Pharmaceutical Co., Ltd.
 patents

Years Active: 1979-1994

Loading Chart...
33 patents (USPTO):
1. 5292926 - Cysteine derivatives (1994-03-08),
2. 5153198 - Agent for treatment of disorders of the cerebro-neural transmission (1992-10-06),
3. 5128467 - Cyclic sulfur-containing compounds (1992-07-07),
4. 5087627 - Agent for treatment of disorders of the cerebro-neural transmission (1992-02-11),
5. 5082836 - Compositions and methods of use of cyclic sulfur-containing compounds (1992-01-21),
6. 5041435 - Cyclic sulfur-containing compounds (1991-08-20),
7. 5034230 - Anti-allergic ophthalmics (1991-07-23),
8. 4786635 - Novel benzothiazine derivatives (1988-11-22),
9. 4584300 - Platelet anti-aggregative- and calcium antagonistic (1986-04-22),
10. 4558125 - Benzothiazoline compounds which contain a carbonyl group useful for (1985-12-10),
11. 4552969 - 3-Alkanoyl benzothiazoline compounds useful for treating cardiovascular (1985-11-12),
12. 4552765 - Aletheine derivatives (1985-11-12),
13. 4547513 - 2-Arylbenzothiazoline derivatives and their use in treating angina cordis (1985-10-15),
14. 4517123 - Cysteine derivatives of disulfide form (1985-05-14),
15. 4499102 - Thiazolidine and pyrrolidine compounds and pharmaceutical compositions (1985-02-12),

Title: Tadashi Iso: Innovator in Immunomodulation and Neurological Treatments

Introduction

Tadashi Iso, based in Sakai, Japan, is a prominent inventor with a remarkable portfolio of 33 patents. His contributions to the field of pharmaceuticals, particularly in immunomodulation and treatments for neurological disorders, have significantly advanced medical science.

Latest Patents

Among his latest inventions, Iso has developed cysteine derivatives that serve as immunomodulators and provide treatment for liver disorders. These compounds are defined by a specific formula and are noted for their potential medicinal benefits. Another recent patent includes a compound aimed at treating disorders of cerebro-neural transmission, providing a promising solution for various neurological issues.

Career Highlights

Iso is currently affiliated with Santen Pharmaceutical Co., Ltd., a company dedicated to the development of innovative eye care solutions. His work at Santen has been instrumental in advancing the company's research and development initiatives, particularly in the areas of immunology and neurology.

Collaborations

Throughout his career, Iso has collaborated with notable colleagues such as Masayuki Oya and Jun-ichi Iwao. These partnerships have enriched his research activities, fostering an environment of innovation and shared expertise.

Conclusion

Tadashi Iso continues to be a vital player in the realm of pharmaceutical innovation. His extensive patent portfolio and collaborative efforts showcase his commitment to enhancing healthcare solutions, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…